W. Kim

Interleukin-6: a candidate mediator of human prostate cancer morbidity.

J. Simons, M. Carducci, M. Eisenberger, 1995, Urology.

Increased expression of Toll-like receptor 5 during progression of cervical neoplasia

S. Song, D. Bae, B. Kim, 2007, International Journal of Gynecologic Cancer.

Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

G. Mills, B. Győrffy, K. Jeong, 2017, Oncogene.

Survival of advanced epithelial ovarian/fallopian tube/primary peritoneum carcinoma after high-complexity upper abdominal surgery

S. Nam, W. Kim, K. O. Jung, 2019, European Journal of Gynaecological Oncology.

Glucocorticoid-mediated repression of inflammatory cytokine production in fibroblast-like rheumatoid synoviocytes is independent of nuclear factor-kappaB activation induced by tumour necrosis factor alpha.

G. Oh, C. Han, W. Kim, 2001, Rheumatology.

Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma.

D. Heo, Y. Jeon, T. Kim, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

Y. Ito, H. Wee, S. Bae, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Prognostic factors associated with brain metastases from epithelial ovarian carcinoma

C. Choi, B. Kim, J.-H. Lee, 2007, International Journal of Gynecologic Cancer.

Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta.

Y. Ito, M. H. Werner, K. Shigesada, 1999, Nature structural biology.